Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
440,400
-
Share change
-
+106,441
-
Total reported value
-
$1,010,250
-
Price per share
-
$2.29
-
Number of holders
-
17
-
Value change
-
+$269,050
-
Number of buys
-
10
-
Number of sells
-
3
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q4 2022
As of 31 Dec 2022,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
440,400 shares.
The largest 10 holders included
VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, Murchinson Ltd., STATE STREET CORP, BOOTHBAY FUND MANAGEMENT, LLC, Lynwood Capital Management Inc., Moss Adams Wealth Advisors LLC, NORTHERN TRUST CORP, InterOcean Capital Group, LLC, and BANK OF MONTREAL /CAN/.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.